Product Information
NORVASC 2.5 MG TABLET is a brand product labeled by Pfizer Inc., priced at $8.7038 per EA under NDC 00069152068. Its NADAC has been published 518 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the amlodipine besylate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/1
Manufacturer
Pfizer Inc.NDC
00069152068
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
AMLODIPINE BESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA019787On Market Since
7/31/1992
Pharmacological Classes
Price Statistics
The NADAC for NORVASC 2.5 MG TABLET has been published 518 times since Nov 28, 2013, and over the history we have for it it has risen 206.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.7038 per EA |
|---|---|
| All-time high | $8.7038 (Jun 24, 2026) |
| All-time low | $2.8411 (Nov 28, 2013) |
| 52-week high | $8.7038 |
| 52-week low | $8.2370 |
| Median price | $5.9900 |
| Average price | $5.8033 |
| Largest weekly change | +16.8% (Sep 18, 2024) |
| Weeks tracked | 518 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NORVASC 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NORVASC 2.5 MG TABLET, manufactured by Pfizer Inc., is $8.7038 per EA (NDC 00069152068), effective Jun 24, 2026.
How has the price of NORVASC 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for NORVASC 2.5 MG TABLET has risen 206.4%. It has been tracked across 518 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NORVASC 2.5 MG TABLET?
Since Nov 28, 2013, the NADAC for NORVASC 2.5 MG TABLET has ranged from a low of $2.8411 (Nov 28, 2013) to a high of $8.7038 (Jun 24, 2026), with a median of $5.9900 per EA.
Are there cheaper alternatives to NORVASC 2.5 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, AMLODIPINE BESYLATE 2.5 MG TAB, is $0.0106 per EA — about 100% below NORVASC 2.5 MG TABLET.
Who manufactures NORVASC 2.5 MG TABLET?
NORVASC 2.5 MG TABLET (NDC 00069152068) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification